MARATHON MICROCATHETER
Report
- Report Number
- 2029214-2014-00530
- Event Type
- Injury
- Date Received
- September 17, 2014
- Report Date
- August 19, 2014
- Manufacturer
- EV3 NEUROVASCULAR
- Product Code
- DYG
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER
Narratives
THE DEVICE INVOLVED IN THE EVENT HAS NOT BEEN RETURNED FOR EVALUATION. (B)(4).
THE CATHETER WAS RETURNED FOR EVALUATION AND IT WAS FOUND TO BE RUPTURED AT APPROXIMATELY 6CM FROM THE DISTAL TIP OF THE CATHETER. THE CATHETER APPEARED TO HAVE BEEN RUPTURED DURING THE ONYX DELIVERY DUE TO OVER-PRESSURIZATION AS A RESULT OF AN UNDETECTED KINK OR OTHER OBSTRUCTION OF THE CATHETER, RESULTING IN PRESSURES EXCEEDING THE LIMITS OF THE CATHETER. ALL PRODUCTS ARE 100% INSPECTED FOR DAMAGE AND IRREGULARITIES DURING MANUFACTURE. PER THE ONYX INSTRUCTION FOR USE: STOP INJECTION IF INCREASED RESISTANCE TO ONYX LES INJECTION IS OBSERVED. IF INCREASED RESISTANCE OCCURS, DETERMINE THE CAUSE (E.G., ONYX LES OCCLUSION IN CATHETER LUMEN) AND REPLACE THE CATHETER. DO NOT ATTEMPT TO CLEAR OR OVERCOME RESISTANCE BY APPLYING INCREASED INJECTION PRESSURE, AS USE OF EXCESSIVE PRESSURE MAY RESULT IN CATHETER RUPTURE AND EMBOLIZATION OF UNINTENDED AREAS. DO NOT INTERRUPT ONYX LES INJECTION FOR LONGER THAN TWO MINUTES PRIOR TO RE-INJECTION. SOLIDIFICATION OF ONYX LES MAY OCCUR AT THE CATHETER TIP RESULTING IN CATHETER OCCLUSION, AND USE OF EXCESSIVE PRESSURE TO CLEAR THE CATHETER MAY RESULT IN CATHETER RUPTURE. (B)(4).
THE PATIENT UNDERWENT ONYX EMBOLIZATION TREATMENT ON AN UNSPECIFIED DATE. DURING THE ONYX INJECTION, IT WAS REPORTED THE ONYX WAS LEAKING DUE TO A BREAK IN THE MICROCATHETER. NO FURTHER INFORMATION WAS AVAILABLE. SAME EVENT AS MDR# 2029214-2014-00543.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 576100 | MARATHON MICROCATHETER | FLOW-DIRECTED MICROCATHETER | DYG | EV3 NEUROVASCULAR | 105-5055 | 9595427 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Disability |